---
title: "GOLDSTONE ASIA PHARM: Domperidone Tablets Selected for Continued Procurement"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/277425466.md"
description: "GOLDSTONE ASIA PHARM announced that its wholly-owned subsidiary Hainan Asia Pharmaceutical participated in the bidding for the continuation procurement of drugs after the expiration of the national organized procurement agreement and successfully won the bid for Domperidone Tablets. The result was announced by the Continuation Procurement Office on February 27, 2026"
datetime: "2026-03-02T08:01:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277425466.md)
  - [en](https://longbridge.com/en/news/277425466.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277425466.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/277425466.md) | [繁體中文](https://longbridge.com/zh-HK/news/277425466.md)


# GOLDSTONE ASIA PHARM: Domperidone Tablets Selected for Continued Procurement

According to the announcement from GOLDSTONE ASIA PHARM (300434.SZ), its wholly-owned first-level subsidiary Hainan Asia Pharmaceutical Co., Ltd. (hereinafter referred to as "Asia Pharmaceutical") participated in the bidding work organized by the National Organization for the Continuation of Procurement of Drugs after the expiration of the national organized procurement drug agreement (hereinafter referred to as "Continuation Procurement Office"). According to the notice issued by the Continuation Procurement Office on February 27, 2026, regarding the announcement of the selected results for the continuation procurement of drugs after the expiration of the national organized procurement drug agreement, Asia Pharmaceutical's product Domperidone Tablets was selected in this continuation procurement

### 相关股票

- [GOLDSTONE ASIA PHARM (300434.CN)](https://longbridge.com/zh-CN/quote/300434.CN.md)

## 相关资讯与研究

- [MORE U.S. FEB TRADE:  CONSUMER GOODS IMPORTS UP $2.2 BILLION, INCLUDING INCREASE OF $1.1 BILLION OF PHARMACEUTICALS](https://longbridge.com/zh-CN/news/281525534.md)
- [Trump administration unveils up to 100% tariff on branded drugs](https://longbridge.com/zh-CN/news/281574074.md)
- [Amgen Expands Thyroid Eye Disease Bet With New AMG 732 Rollover Study](https://longbridge.com/zh-CN/news/281652414.md)
- [Addtech boosts System Security unit with acquisition of Dutch enclosure specialist Staka](https://longbridge.com/zh-CN/news/281410681.md)
- [Drugs Made in America Delays Annual Filing](https://longbridge.com/zh-CN/news/281437028.md)